Heart failure: Diagnosis of heart failure in primary care

Heart

Volumn 96, Issue 21, 2010, Pages 1773-1777

  Hobbs, F D R ^a   Doust, J ^a   Mant, J ^a   Cowie, M R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER;

CLINICAL DECISION MAKING; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; HEALTH CARE SYSTEM; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MORBIDITY; PATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; ALGORITHM; BLOOD; EVIDENCE BASED MEDICINE; FEMALE; MALE; PRIMARY HEALTH CARE; PROCEDURES;

ALGORITHMS; BIOLOGICAL MARKERS; EVIDENCE-BASED MEDICINE; FEMALE; HEART FAILURE; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE;

EID: 78049273742     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2007.139402     Document Type: Review

References (20)

1. Gillum RF. Epidemiology of heart failure in the United States. Am Heart J 1993;126:1042-7. [CrossRef] [Medline] [Web of Science]
2. Hobbs FDR, Roalfe AK, Davis RC, et al. Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES). Eur Heart J 2007;28:1128-34. [Abstract/FREE Full text] Useful recent mortality data that encompass outcomes in all grades (mild to severe) of heart failure in a prior screened UK population.
3. McKee PA, Castelli WP, McNamara PM, et al. The natural history of heart failure: the Framingham study. N Engl J Med 1971;285:1441-6. [Medline] [Web of Science]
4. McDonagh TA, Morrison CE, Lawrence A, et al. Symptomatic and asymptomatic left ventricular systolic dysfunction in an urban population. Lancet 1997;350:829-33. [CrossRef] [Medline] [Web of Science] (Pubitemid 27404343)
5. Davies MK, Hobbs FDR, Davis RC, et al. Prevalence of left ventricular systolic dysfunction and heart failure in the general population: main findings from the ECHOES (Echocardiographic Heart of England Screening) Study. Lancet 2001;358:439-45. [CrossRef] [Medline] [Web of Science] The largest of the UK heart failure cohorts identified by random population screening.
6. Cowie MR, Wood DA, Coats A, et al. Incidence and aetiology of heart failure: a population-based study. Eur Heart J 1999;20:421-8. [Abstract/FREE Full text] The best estimates on the current incidence of heart failure in the UK.
7. Cleland JG, Swedberg K, Follath F, et al.; Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe Part 1: patient characteristics and diagnosis. Eur Heart J 2003;24:442-63. [Abstract/FREE Full text]
8. Garg R, Yusuf S; for the Collaborative Group on ACE Inhibitor Trials. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995;273:1450-6. [Abstract/FREE Full text] The pooled data for the effectiveness of ACE inhibitors in heart failure.
9. Lechat P, Packer M, Chalon S, et al. Beta-blockers in heart failure: meta-analysis of randomized trials. Circulation 1998;98:1184-91. [Abstract/FREE Full text] Pooled data on the effectiveness of β-blockers in heart failure.
10. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112:154-235. [FREE Full text] The current main US guidelines for diagnosis and management of heart failure.
11. Dickstein K, Cohen-Solal A, Filippatos G, et al.; Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-442. [FREE Full text] The most recent ESC guidance on the diagnosis of heart failure.
12. National Collaborating Centre for Chronic Conditions on behalf of the National Institute for Clinical Excellence. Chronic heart failure: management of chronic heart failure in adults in primary and secondary care. Salisbury. Royal College of Physicians 2003. http://www.rcplondon.ac.uk/pubs/books/chf/ heartfailure.pdf. The current NICE heart failure guidelines on diagnosis and management, though the revised update is due sometime in 2010.
13. Hobbs FDR, Davis RC, Roalfe AK, et al. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ 2002;324:1498-503. [Abstract/FREE Full text]
14. Mant J, Doust J, Roalfe A, et al. Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Technology Assessment 2009;13:1-207, iii. The most recent systematic review on the diagnostic options for heart failure w hich includes an individual patient data meta-analysis on the utility of BNP testing.
15. Doust JA, Glasziou PP, Pietrzak E, et al. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 2004;164:1978-84. [Abstract/FREE Full text]
16. Khunti K, Squire I, Abrams KR, et al. Accuracy of a 12-lead electrocardiogram in screening patients with suspected heart failure for open access echocardiography: a systematic review and meta-analysis. Eur J Heart Fail 2004;6:571-6. [Abstract/FREE Full text] (Pubitemid 39070511)
17. Davenport C, Cheng EYL, Kwok YTT, et al. Assessing the diagnostic test accuracy of natriuretic peptides and ECG in the diagnosis of left ventricular systolic dysfunction: a systematic review and meta-analysis. Br J Gen Pract 2006;56:48-56. [Medline] [Web of Science] (Pubitemid 43078217)
18. Latour-Perez J, Coves-Orts FJ, Abad-Terrado C, et al. Accuracy of B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: a systematic review. Eur J Heart Fail 2006;8:390-9. [Abstract/FREE Full text]
19. Paulus WJ, Tschope C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007;28:2539-50. [Abstract/FREE Full text] Consensus guidelines on the diagnosis of preserved systolic function heart failure.
20. Mosterd A, Deckers JW, Hoes AW, et al. Classification of heart failure in population based research: an assessment of six heart failure scores. Eur J Epidemiol 1997;13:491-502. [CrossRef] [Medline] [Web of Science]